SIMILAR PATTERNS OF AMINO ACIDS FOR 1XOM_B_CIOB601_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cx1 ENDOGLUCANASE C

(Cellulomonas
fimi)
PF02018
(CBM_4_9)
5 LEU A  68
ILE A 143
MET A  37
PHE A  15
PHE A 131
None
1.33A 1xomB-1cx1A:
undetectable
1xomB-1cx1A:
18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dct PROTEIN
(MODIFICATION
METHYLASE HAEIII)


(Haemophilus
influenzae)
PF00145
(DNA_methylase)
5 LEU A  90
ILE A  97
PHE A  59
SER A   5
PHE A   7
None
1.17A 1xomB-1dctA:
undetectable
1xomB-1dctA:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gtu GLUTATHIONE
S-TRANSFERASE


(Homo sapiens)
PF02798
(GST_N)
PF14497
(GST_C_3)
5 TYR A 126
LEU A 165
ILE A 113
PHE A 119
PHE A 208
None
1.14A 1xomB-1gtuA:
undetectable
1xomB-1gtuA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1js8 HEMOCYANIN

(Enteroctopus
dofleini)
PF00264
(Tyrosinase)
PF14830
(Haemocyan_bet_s)
5 HIS A2671
LEU A2574
THR A2566
MET A2564
GLN A2561
CUO  A 888 (-3.4A)
None
None
None
None
1.30A 1xomB-1js8A:
undetectable
1xomB-1js8A:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1m2p CASEIN KINASE II,
ALPHA CHAIN


(Zea mays)
PF00069
(Pkinase)
5 HIS A 154
LEU A  85
ILE A 174
MET A 163
PHE A 113
None
None
HNA  A 351 (-3.8A)
HNA  A 351 ( 3.8A)
HNA  A 351 (-3.6A)
1.43A 1xomB-1m2pA:
undetectable
1xomB-1m2pA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mio NITROGENASE
MOLYBDENUM IRON
PROTEIN (BETA CHAIN)


(Clostridium
pasteurianum)
PF00148
(Oxidored_nitro)
5 TYR B 118
LEU B 111
ILE B  84
SER B  70
PHE B  71
None
1.46A 1xomB-1mioB:
undetectable
1xomB-1mioB:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qbg NAD(P)H
DEHYDROGENASE
[QUINONE] 1


(Homo sapiens)
PF02525
(Flavodoxin_2)
5 THR A 148
ILE A 192
PHE A  17
MET A  21
SER A 145
FAD  A 501 (-3.9A)
FAD  A 501 (-4.5A)
FAD  A 501 (-4.9A)
None
None
1.10A 1xomB-1qbgA:
undetectable
1xomB-1qbgA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1r55 ADAM 33

(Homo sapiens)
PF01421
(Reprolysin)
5 MET A 319
LEU A 405
THR A 250
MET A 373
SER A 389
None
1.45A 1xomB-1r55A:
undetectable
1xomB-1r55A:
17.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rep PROTEIN (REPLICATION
INITIATION PROTEIN)


(Escherichia
coli)
PF01051
(Rep_3)
5 TYR C 192
LEU C 169
ILE C 188
PHE C 204
PHE C 240
None
1.43A 1xomB-1repC:
undetectable
1xomB-1repC:
20.57
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1soj CGMP-INHIBITED
3',5'-CYCLIC
PHOSPHODIESTERASE B


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 736
HIS A 737
THR A 952
ILE A 955
PHE A 959
GLN A 988
PHE A 991
IBM  A2111 (-4.5A)
IBM  A2111 ( 4.8A)
IBM  A2111 ( 4.8A)
IBM  A2111 (-4.2A)
None
IBM  A2111 (-3.3A)
IBM  A2111 (-3.6A)
0.54A 1xomB-1sojA:
42.3
1xomB-1sojA:
31.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u2v ACTIN-RELATED
PROTEIN 3
ARP2/3 COMPLEX 34KDA
SUBUNIT


(Bos taurus)
PF00022
(Actin)
PF04045
(P34-Arc)
5 HIS D 263
THR A 126
ILE A 129
MET A 130
PHE A 134
None
1.27A 1xomB-1u2vD:
undetectable
1xomB-1u2vD:
21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uf2 CORE PROTEIN P3

(Rice dwarf
virus)
PF09231
(RDV-p3)
5 LEU A 642
THR A 559
ILE A 562
SER A 589
PHE A 591
None
1.38A 1xomB-1uf2A:
undetectable
1xomB-1uf2A:
16.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wu2 MOLYBDOPTERIN
BIOSYNTHESIS MOEA
PROTEIN


(Pyrococcus
horikoshii)
PF00994
(MoCF_biosynth)
PF03453
(MoeA_N)
PF03454
(MoeA_C)
5 TYR A  10
LEU A  17
ILE A 281
SER A 297
PHE A 287
None
1.41A 1xomB-1wu2A:
undetectable
1xomB-1wu2A:
22.01
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1zkl HIGH-AFFINITY
CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 7A


(Homo sapiens)
PF00233
(PDEase_I)
5 TYR A 211
HIS A 212
PHE A 384
GLN A 413
PHE A 416
IBM  A 503 (-4.6A)
None
IBM  A 503 (-4.5A)
IBM  A 503 (-3.0A)
IBM  A 503 (-3.4A)
0.61A 1xomB-1zklA:
45.4
1xomB-1zklA:
33.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1znp HYPOTHETICAL PROTEIN
ATU3615


(Agrobacterium
fabrum)
PF06172
(Cupin_5)
5 TYR A  25
HIS A  19
THR A  28
ILE A  43
SER A  40
None
1.35A 1xomB-1znpA:
undetectable
1xomB-1znpA:
16.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a3v SITE-SPECIFIC
RECOMBINASE INTI4


(Vibrio cholerae)
PF00589
(Phage_integrase)
PF13495
(Phage_int_SAM_4)
5 LEU A  83
THR A  31
ILE A  34
SER A   3
PHE A   5
None
1.21A 1xomB-2a3vA:
undetectable
1xomB-2a3vA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2avt DNA POLYMERASE III
BETA SUBUNIT


(Streptococcus
pyogenes)
PF00712
(DNA_pol3_beta)
PF02767
(DNA_pol3_beta_2)
PF02768
(DNA_pol3_beta_3)
5 LEU A 325
ILE A 299
PHE A 266
SER A 319
GLN A 320
None
1.37A 1xomB-2avtA:
undetectable
1xomB-2avtA:
23.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eyu TWITCHING MOTILITY
PROTEIN PILT


(Aquifex
aeolicus)
PF00437
(T2SSE)
5 MET A 218
LEU A 140
THR A 152
ILE A 153
SER A 147
None
1.46A 1xomB-2eyuA:
undetectable
1xomB-2eyuA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eyu TWITCHING MOTILITY
PROTEIN PILT


(Aquifex
aeolicus)
PF00437
(T2SSE)
5 MET A 218
THR A 152
ILE A 153
SER A 147
GLN A 279
None
1.47A 1xomB-2eyuA:
undetectable
1xomB-2eyuA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h18 ADP-RIBOSYLATION
FACTOR-LIKE PROTEIN
8A


(Homo sapiens)
PF00025
(Arf)
5 LEU A 128
THR A  24
ILE A  67
MET A  21
SER A  90
None
1.20A 1xomB-2h18A:
undetectable
1xomB-2h18A:
24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h2q BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Trypanosoma
cruzi)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
5 LEU A 496
THR A 375
ILE A 372
MET A 385
PHE A 409
None
1.50A 1xomB-2h2qA:
undetectable
1xomB-2h2qA:
19.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10


(Homo sapiens)
PF00233
(PDEase_I)
12 TYR A 371
HIS A 372
MET A 485
LEU A 531
THR A 545
ILE A 548
MET A 549
PHE A 552
MET A 569
SER A 580
GLN A 581
PHE A 584
NPV  A   3 (-4.4A)
NPV  A   3 (-4.6A)
None
None
NPV  A   3 ( 4.7A)
NPV  A   3 (-3.8A)
NPV  A   3 ( 4.7A)
NPV  A   3 (-4.8A)
NPV  A   3 (-3.1A)
NPV  A   3 (-4.5A)
NPV  A   3 (-3.1A)
NPV  A   3 (-3.3A)
0.43A 1xomB-2qykA:
52.0
1xomB-2qykA:
82.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 371
HIS A 376
MET A 485
THR A 545
SER A 580
GLN A 581
PHE A 584
NPV  A   3 (-4.4A)
ZN  A   1 (-3.3A)
None
NPV  A   3 ( 4.7A)
NPV  A   3 (-4.5A)
NPV  A   3 (-3.1A)
NPV  A   3 (-3.3A)
1.48A 1xomB-2qykA:
52.0
1xomB-2qykA:
82.16
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qym PHOSPHODIESTERASE 4C

(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 281
HIS A 282
MET A 395
LEU A 441
THR A 455
ILE A 458
PHE A 494
None
0.46A 1xomB-2qymA:
43.6
1xomB-2qymA:
82.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r8q CLASS I
PHOSPHODIESTERASE
PDEB1


(Leishmania
major)
PF00233
(PDEase_I)
7 TYR A 680
HIS A 681
MET A 797
PHE A 857
MET A 874
GLN A 887
PHE A 890
IBM  A   3 ( 4.7A)
IBM  A   3 ( 4.8A)
None
IBM  A   3 (-4.9A)
IBM  A   3 ( 3.8A)
IBM  A   3 (-3.3A)
IBM  A   3 (-3.6A)
0.83A 1xomB-2r8qA:
39.4
1xomB-2r8qA:
30.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2x1m METHIONYL-TRNA
SYNTHETASE


(Mycolicibacterium
smegmatis)
PF09334
(tRNA-synt_1g)
5 TYR A  45
MET A 409
THR A   8
ILE A   7
PHE A   5
None
1.15A 1xomB-2x1mA:
undetectable
1xomB-2x1mA:
22.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xgt ASPARAGINYL-TRNA
SYNTHETASE,
CYTOPLASMIC


(Brugia malayi)
PF00152
(tRNA-synt_2)
PF01336
(tRNA_anti-codon)
5 THR A 174
ILE A 133
MET A 136
PHE A 146
MET A 144
None
1.42A 1xomB-2xgtA:
undetectable
1xomB-2xgtA:
21.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2r CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
6 TYR A 612
HIS A 613
LEU A 765
PHE A 786
GLN A 817
PHE A 820
VDN  A   1 (-4.8A)
VDN  A   1 (-4.3A)
VDN  A   1 ( 4.7A)
None
VDN  A   1 (-3.0A)
VDN  A   1 (-3.6A)
0.68A 1xomB-3b2rA:
31.6
1xomB-3b2rA:
31.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bjc CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
6 TYR A 612
HIS A 613
LEU A 765
PHE A 786
GLN A 817
PHE A 820
None
MG  A 877 (-4.4A)
WAN  A 901 ( 4.7A)
WAN  A 901 (-4.8A)
WAN  A 901 (-3.1A)
WAN  A 901 (-3.7A)
0.71A 1xomB-3bjcA:
34.3
1xomB-3bjcA:
17.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ecn HIGH AFFINITY
CAMP-SPECIFIC AND
IBMX-INSENSITIVE
3',5'-CYCLIC
PHOSPHODIESTERASE 8A


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 555
HIS A 556
MET A 670
ILE A 744
SER A 777
GLN A 778
PHE A 781
None
None
IBM  A   3 (-4.5A)
IBM  A   3 (-4.3A)
None
IBM  A   3 (-3.4A)
IBM  A   3 (-3.5A)
0.41A 1xomB-3ecnA:
45.0
1xomB-3ecnA:
33.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
9 TYR A 325
HIS A 326
MET A 439
LEU A 485
ILE A 502
MET A 503
PHE A 506
SER A 534
PHE A 538
None
D71  A 901 (-4.5A)
D71  A 901 ( 4.0A)
None
D71  A 901 (-4.1A)
D71  A 901 (-3.6A)
D71  A 901 (-4.8A)
D71  A 901 (-3.4A)
D71  A 901 (-3.9A)
0.88A 1xomB-3g4gA:
52.8
1xomB-3g4gA:
81.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
10 TYR A 325
HIS A 326
MET A 439
LEU A 485
THR A 499
ILE A 502
MET A 503
PHE A 506
GLN A 535
PHE A 538
None
D71  A 901 (-4.5A)
D71  A 901 ( 4.0A)
None
D71  A 901 (-3.6A)
D71  A 901 (-4.1A)
D71  A 901 (-3.6A)
D71  A 901 (-4.8A)
D71  A 901 (-3.1A)
D71  A 901 (-3.9A)
0.66A 1xomB-3g4gA:
52.8
1xomB-3g4gA:
81.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
6 TYR A 325
ILE A 502
MET A 503
MET A 523
SER A 534
PHE A 538
None
D71  A 901 (-4.1A)
D71  A 901 (-3.6A)
D71  A 901 ( 4.0A)
D71  A 901 (-3.4A)
D71  A 901 (-3.9A)
1.02A 1xomB-3g4gA:
52.8
1xomB-3g4gA:
81.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 325
THR A 499
ILE A 502
MET A 503
MET A 523
GLN A 535
PHE A 538
None
D71  A 901 (-3.6A)
D71  A 901 (-4.1A)
D71  A 901 (-3.6A)
D71  A 901 ( 4.0A)
D71  A 901 (-3.1A)
D71  A 901 (-3.9A)
0.70A 1xomB-3g4gA:
52.8
1xomB-3g4gA:
81.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gwj ARYLPHORIN

(Antheraea
pernyi)
PF00372
(Hemocyanin_M)
PF03722
(Hemocyanin_N)
PF03723
(Hemocyanin_C)
5 LEU A 154
THR A 295
PHE A 395
SER A 298
PHE A 297
None
1.39A 1xomB-3gwjA:
undetectable
1xomB-3gwjA:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h5c PROTEIN Z-DEPENDENT
PROTEASE INHIBITOR


(Homo sapiens)
PF00079
(Serpin)
5 LEU A 362
ILE A 203
PHE A 174
MET A 172
PHE A 200
None
1.44A 1xomB-3h5cA:
undetectable
1xomB-3h5cA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hoc FILAMIN-A

(Homo sapiens)
PF00307
(CH)
5 LEU A 172
THR A 186
ILE A 185
SER A 189
PHE A 188
None
1.33A 1xomB-3hocA:
undetectable
1xomB-3hocA:
23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hzt CALCIUM-DEPENDENT
PROTEIN KINASE 3


(Toxoplasma
gondii)
PF00069
(Pkinase)
PF13499
(EF-hand_7)
5 TYR A 242
MET A 180
LEU A 268
GLN A 360
PHE A 162
None
1.48A 1xomB-3hztA:
undetectable
1xomB-3hztA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ibj CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
PF01590
(GAF)
PF13185
(GAF_2)
6 TYR A 655
HIS A 656
LEU A 809
ILE A 826
GLN A 859
PHE A 862
None
1.04A 1xomB-3ibjA:
32.8
1xomB-3ibjA:
18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3jbl NLR FAMILY CARD
DOMAIN-CONTAINING
PROTEIN 4


(Mus musculus)
no annotation 5 TYR K 493
THR K 450
PHE K 363
GLN K 447
PHE K 406
None
1.31A 1xomB-3jblK:
undetectable
1xomB-3jblK:
18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ldg PUTATIVE
UNCHARACTERIZED
PROTEIN SMU.472


(Streptococcus
mutans)
PF01170
(UPF0020)
PF02926
(THUMP)
5 LEU A 292
ILE A 341
PHE A 348
GLN A 339
PHE A 331
SAH  A 385 (-3.8A)
None
None
None
None
1.17A 1xomB-3ldgA:
undetectable
1xomB-3ldgA:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 233
HIS A 234
MET A 347
LEU A 393
THR A 407
ILE A 410
MET A 411
MET A 431
SER A 442
GLN A 443
PHE A 446
None
None
ZG2  A 506 (-3.9A)
None
ZG2  A 506 (-4.3A)
ZG2  A 506 (-4.4A)
None
ZG2  A 506 (-3.4A)
None
ZG2  A 506 (-3.3A)
ZG2  A 506 (-3.6A)
0.64A 1xomB-3o57A:
51.9
1xomB-3o57A:
82.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 233
HIS A 234
MET A 347
LEU A 393
THR A 407
ILE A 410
MET A 411
PHE A 414
SER A 442
GLN A 443
PHE A 446
None
None
ZG2  A 506 (-3.9A)
None
ZG2  A 506 (-4.3A)
ZG2  A 506 (-4.4A)
None
ZG2  A 506 (-4.4A)
None
ZG2  A 506 (-3.3A)
ZG2  A 506 (-3.6A)
0.59A 1xomB-3o57A:
51.9
1xomB-3o57A:
82.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
PF00233
(PDEase_I)
12 TYR A 159
HIS A 160
MET A 273
LEU A 319
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
GLN A 369
PHE A 372
TYR  A 159 (-1.3A)
HIS  A 160 ( 1.0A)
MET  A 273 (-0.0A)
LEU  A 319 ( 0.6A)
THR  A 333 ( 0.8A)
ILE  A 336 ( 0.4A)
MET  A 337 ( 0.0A)
PHE  A 340 (-1.3A)
MET  A 357 (-0.0A)
SER  A 368 (-0.0A)
GLN  A 369 (-0.6A)
PHE  A 372 (-1.3A)
0.59A 1xomB-3sl5A:
52.8
1xomB-3sl5A:
94.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ui7 CAMP AND
CAMP-INHIBITED CGMP
3',5'-CYCLIC
PHOSPHODIESTERASE
10A


(Homo sapiens)
PF00233
(PDEase_I)
5 TYR A 524
HIS A 525
LEU A 635
ILE A 692
PHE A 729
C1L  A   1 ( 4.8A)
C1L  A   1 (-4.1A)
None
C1L  A   1 (-4.3A)
C1L  A   1 (-3.5A)
1.47A 1xomB-3ui7A:
38.5
1xomB-3ui7A:
28.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ui7 CAMP AND
CAMP-INHIBITED CGMP
3',5'-CYCLIC
PHOSPHODIESTERASE
10A


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 524
HIS A 525
LEU A 675
ILE A 692
PHE A 696
GLN A 726
PHE A 729
C1L  A   1 ( 4.8A)
C1L  A   1 (-4.1A)
C1L  A   1 (-4.3A)
C1L  A   1 (-4.3A)
C1L  A   1 ( 4.7A)
C1L  A   1 (-2.9A)
C1L  A   1 (-3.5A)
0.93A 1xomB-3ui7A:
38.5
1xomB-3ui7A:
28.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ui7 CAMP AND
CAMP-INHIBITED CGMP
3',5'-CYCLIC
PHOSPHODIESTERASE
10A


(Homo sapiens)
PF00233
(PDEase_I)
6 TYR A 524
LEU A 675
ILE A 692
MET A 713
GLN A 726
PHE A 729
C1L  A   1 ( 4.8A)
C1L  A   1 (-4.3A)
C1L  A   1 (-4.3A)
C1L  A   1 (-3.7A)
C1L  A   1 (-2.9A)
C1L  A   1 (-3.5A)
1.25A 1xomB-3ui7A:
38.5
1xomB-3ui7A:
28.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3v94 CYCLIC NUCLEOTIDE
SPECIFIC
PHOSPHODIESTERASE


(Trypanosoma
cruzi)
PF00233
(PDEase_I)
7 TYR A 367
HIS A 368
MET A 482
ILE A 538
PHE A 542
GLN A 570
PHE A 573
WYQ  A 701 (-4.5A)
None
WYQ  A 701 (-4.5A)
WYQ  A 701 ( 4.1A)
WYQ  A 701 (-4.7A)
WYQ  A 701 (-3.3A)
WYQ  A 701 (-3.4A)
0.81A 1xomB-3v94A:
40.2
1xomB-3v94A:
30.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4esa HEMOGLOBIN BETA
CHAIN


(Eleginops
maclovinus)
PF00042
(Globin)
5 LEU B  71
PHE B 122
MET B 118
SER B  17
PHE B  15
HEM  B 202 ( 4.7A)
None
None
None
None
1.50A 1xomB-4esaB:
undetectable
1xomB-4esaB:
17.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hl6 UNCHARACTERIZED
PROTEIN YFDE


(Escherichia
coli)
PF02515
(CoA_transf_3)
5 MET A 106
LEU A  97
ILE A 119
SER A  85
PHE A  87
None
1.33A 1xomB-4hl6A:
undetectable
1xomB-4hl6A:
25.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4htz CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 655
HIS A 656
LEU A 809
ILE A 826
PHE A 830
GLN A 859
PHE A 862
None
0.67A 1xomB-4htzA:
38.9
1xomB-4htzA:
28.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4htz CGMP-DEPENDENT
3',5'-CYCLIC
PHOSPHODIESTERASE


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 655
LEU A 809
ILE A 826
PHE A 830
MET A 847
GLN A 859
PHE A 862
None
0.92A 1xomB-4htzA:
38.9
1xomB-4htzA:
28.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4i15 CLASS 1
PHOSPHODIESTERASE
PDEB1


(Trypanosoma
brucei)
PF00233
(PDEase_I)
7 TYR A 668
HIS A 669
MET A 785
PHE A 844
MET A 861
GLN A 874
PHE A 877
None
0.93A 1xomB-4i15A:
38.6
1xomB-4i15A:
32.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jr7 CASEIN KINASE II
SUBUNIT ALPHA


(Saccharomyces
cerevisiae)
PF00069
(Pkinase)
5 HIS A 193
LEU A  86
ILE A 213
MET A 202
PHE A 152
None
None
GNP  A 401 (-4.6A)
GNP  A 401 (-3.6A)
None
1.45A 1xomB-4jr7A:
undetectable
1xomB-4jr7A:
23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4md8 CASEIN KINASE II
SUBUNIT ALPHA


(Homo sapiens)
PF00069
(Pkinase)
5 HIS E 154
LEU E  85
ILE E 174
MET E 163
PHE E 113
None
1.33A 1xomB-4md8E:
undetectable
1xomB-4md8E:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o8m TRAP DICARBOXYLATE
TRANSPORTER, DCTP
SUBUNIT


(Actinobacillus
succinogenes)
PF03480
(DctP)
5 THR A  27
ILE A  29
PHE A  62
SER A  56
GLN A 253
None
1.47A 1xomB-4o8mA:
undetectable
1xomB-4o8mA:
18.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ofz TREHALOSE-PHOSPHATAS
E


(Brugia malayi)
no annotation 5 MET A  75
LEU A 229
ILE A 130
MET A 119
GLN A 224
None
1.29A 1xomB-4ofzA:
undetectable
1xomB-4ofzA:
22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q8g PAB-DEPENDENT
POLY(A)-SPECIFIC
RIBONUCLEASE SUBUNIT
PAN2


(Saccharomyces
cerevisiae)
PF13423
(UCH_1)
5 MET A 703
LEU A 735
ILE A 695
SER A 773
PHE A 760
None
1.08A 1xomB-4q8gA:
undetectable
1xomB-4q8gA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4q8h PAB-DEPENDENT
POLY(A)-SPECIFIC
RIBONUCLEASE SUBUNIT
PAN2


(Saccharomyces
cerevisiae)
PF00929
(RNase_T)
PF13423
(UCH_1)
5 MET A 703
LEU A 735
ILE A 695
SER A 773
PHE A 760
None
1.12A 1xomB-4q8hA:
undetectable
1xomB-4q8hA:
18.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4v23 MATRIX PROTEIN

(Respiratory
syncytial virus)
PF03393
(Pneumo_matrix)
5 MET A  84
LEU A  52
THR A  33
ILE A  34
SER A 198
None
1.06A 1xomB-4v23A:
undetectable
1xomB-4v23A:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wmd ORF1A

(Middle East
respiratory
syndrome-related
coronavirus)
PF05409
(Peptidase_C30)
5 TYR A  54
MET A  25
LEU A  49
THR A  88
GLN A 167
None
None
PGE  A 402 ( 4.8A)
None
None
1.47A 1xomB-4wmdA:
undetectable
1xomB-4wmdA:
21.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
11 TYR A 405
HIS A 406
MET A 519
LEU A 565
THR A 579
ILE A 582
MET A 583
PHE A 586
SER A 614
GLN A 615
PHE A 618
None
MG  A 804 ( 4.9A)
None
None
None
None
None
None
None
None
None
0.62A 1xomB-4wziA:
52.5
1xomB-4wziA:
48.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
9 TYR A 405
HIS A 406
THR A 579
ILE A 582
MET A 583
PHE A 586
MET A 603
SER A 614
GLN A 615
None
MG  A 804 ( 4.9A)
None
None
None
None
None
None
None
0.84A 1xomB-4wziA:
52.5
1xomB-4wziA:
48.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
PF00233
(PDEase_I)
7 TYR A 405
HIS A 410
MET A 519
LEU A 565
THR A 579
GLN A 615
PHE A 618
None
ZN  A 801 (-3.2A)
None
None
None
None
None
1.45A 1xomB-4wziA:
52.5
1xomB-4wziA:
48.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zbl PHOTOSESITIZER
MKILLERORANGE


(Hydrozoa)
PF01353
(GFP)
5 HIS A  62
THR A 162
ILE A 163
PHE A 165
MET A 173
None
None
4M9  A  65 ( 4.0A)
None
None
1.44A 1xomB-4zblA:
undetectable
1xomB-4zblA:
23.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5b25 CALCIUM/CALMODULIN-D
EPENDENT
3',5'-CYCLIC
NUCLEOTIDE
PHOSPHODIESTERASE 1B


(Homo sapiens)
PF00233
(PDEase_I)
8 TYR A 222
HIS A 223
MET A 336
THR A 385
PHE A 392
SER A 420
GLN A 421
PHE A 424
None
4QJ  A 603 ( 4.9A)
4QJ  A 603 ( 3.9A)
None
GOL  A 607 (-3.9A)
4QJ  A 603 (-4.7A)
4QJ  A 603 (-3.0A)
4QJ  A 603 (-3.5A)
0.62A 1xomB-5b25A:
44.0
1xomB-5b25A:
38.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dmh UNCHARACTERIZED
PROTEIN CONSERVED IN
BACTERIA


(Cupriavidus
necator)
PF07005
(DUF1537)
PF17042
(DUF1357_C)
5 MET A 206
LEU A 169
ILE A 135
SER A  96
PHE A  98
None
1.47A 1xomB-5dmhA:
undetectable
1xomB-5dmhA:
23.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5h2r PHOSPHODIESTERASE

(Trypanosoma
brucei)
no annotation 7 TYR A 668
HIS A 669
MET A 785
PHE A 845
MET A 862
GLN A 875
PHE A 878
LLN  A1003 ( 4.8A)
None
LLN  A1003 (-4.0A)
LLN  A1003 (-4.6A)
LLN  A1003 (-3.5A)
LLN  A1003 (-3.0A)
LLN  A1003 (-3.8A)
0.78A 1xomB-5h2rA:
39.2
1xomB-5h2rA:
32.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ham RICKCE

(Rickettsia
bellii)
no annotation 5 LEU A 580
THR A 565
ILE A 557
MET A 559
PHE A 452
None
1.11A 1xomB-5hamA:
undetectable
1xomB-5hamA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ifk PURINE NUCLEOSIDE
PHOSPHORYLASE


(Kluyveromyces
lactis)
PF01048
(PNP_UDP_1)
5 TYR A  19
LEU A  24
ILE A  65
PHE A  68
PHE A  82
None
1.48A 1xomB-5ifkA:
undetectable
1xomB-5ifkA:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mov CASEIN KINASE II
SUBUNIT ALPHA


(Homo sapiens)
PF00069
(Pkinase)
5 HIS A 154
LEU A  85
ILE A 174
MET A 163
PHE A 113
None
None
HC4  A 401 ( 3.7A)
HC4  A 401 ( 4.0A)
HC4  A 401 (-3.4A)
1.43A 1xomB-5movA:
undetectable
1xomB-5movA:
22.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
no annotation 11 TYR A 405
HIS A 406
MET A 519
LEU A 565
THR A 579
ILE A 582
MET A 583
PHE A 586
MET A 603
GLN A 615
PHE A 618
None
None
9VE  A 801 (-3.8A)
9VE  A 801 (-4.7A)
9VE  A 801 (-4.1A)
9VE  A 801 (-4.1A)
9VE  A 801 ( 4.0A)
9VE  A 801 (-3.6A)
9VE  A 801 (-3.6A)
9VE  A 801 (-3.2A)
9VE  A 801 (-3.9A)
0.58A 1xomB-5ohjA:
52.1
1xomB-5ohjA:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
no annotation 11 TYR A 405
HIS A 406
MET A 519
LEU A 565
THR A 579
ILE A 582
MET A 583
PHE A 586
SER A 614
GLN A 615
PHE A 618
None
None
9VE  A 801 (-3.8A)
9VE  A 801 (-4.7A)
9VE  A 801 (-4.1A)
9VE  A 801 (-4.1A)
9VE  A 801 ( 4.0A)
9VE  A 801 (-3.6A)
9VE  A 801 (-4.7A)
9VE  A 801 (-3.2A)
9VE  A 801 (-3.9A)
0.29A 1xomB-5ohjA:
52.1
1xomB-5ohjA:
11.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B


(Homo sapiens)
no annotation 7 TYR A 405
HIS A 410
MET A 519
LEU A 565
THR A 579
GLN A 615
PHE A 618
None
ZN  A 699 (-3.3A)
9VE  A 801 (-3.8A)
9VE  A 801 (-4.7A)
9VE  A 801 (-4.1A)
9VE  A 801 (-3.2A)
9VE  A 801 (-3.9A)
1.47A 1xomB-5ohjA:
52.1
1xomB-5ohjA:
11.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5vyd PHOSPHODIESTERASE

(Salpingoeca
rosetta)
no annotation 5 HIS A  83
MET A 195
LEU A 237
PHE A 258
PHE A 291
None
0.64A 1xomB-5vydA:
40.1
1xomB-5vydA:
32.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
no annotation 10 TYR A 159
HIS A 160
LEU A 319
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
SER A 368
GLN A 369
AKJ  A 601 ( 4.7A)
None
AKJ  A 601 ( 4.6A)
AKJ  A 601 (-4.1A)
AKJ  A 601 (-3.8A)
AKJ  A 601 ( 3.7A)
AKJ  A 601 (-4.5A)
AKJ  A 601 (-3.4A)
AKJ  A 601 (-2.5A)
AKJ  A 601 (-3.0A)
0.46A 1xomB-5wh6A:
55.1
1xomB-5wh6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
no annotation 11 TYR A 159
HIS A 160
MET A 273
LEU A 319
THR A 333
ILE A 336
MET A 337
PHE A 340
MET A 357
GLN A 369
PHE A 372
AKJ  A 601 ( 4.7A)
None
AKJ  A 601 ( 3.9A)
AKJ  A 601 ( 4.6A)
AKJ  A 601 (-4.1A)
AKJ  A 601 (-3.8A)
AKJ  A 601 ( 3.7A)
AKJ  A 601 (-4.5A)
AKJ  A 601 (-3.4A)
AKJ  A 601 (-3.0A)
AKJ  A 601 (-4.1A)
0.25A 1xomB-5wh6A:
55.1
1xomB-5wh6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D


(Homo sapiens)
no annotation 7 TYR A 159
HIS A 164
MET A 273
LEU A 319
THR A 333
GLN A 369
PHE A 372
AKJ  A 601 ( 4.7A)
ZN  A 602 (-3.3A)
AKJ  A 601 ( 3.9A)
AKJ  A 601 ( 4.6A)
AKJ  A 601 (-4.1A)
AKJ  A 601 (-3.0A)
AKJ  A 601 (-4.1A)
1.49A 1xomB-5wh6A:
55.1
1xomB-5wh6A:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5z9x SMALL RNA DEGRADING
NUCLEASE 1


(Arabidopsis
thaliana)
no annotation 5 HIS A 236
LEU A  85
THR A 138
ILE A 219
MET A 140
None
1.34A 1xomB-5z9xA:
undetectable
1xomB-5z9xA:
12.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zib -

(-)
no annotation 5 ILE A 317
MET A 229
PHE A 235
MET A 238
SER A 302
None
1.25A 1xomB-5zibA:
undetectable
1xomB-5zibA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zic -

(-)
no annotation 5 LEU A 377
THR A 306
ILE A 305
PHE A 235
MET A 238
None
1.40A 1xomB-5zicA:
undetectable
1xomB-5zicA:
undetectable